68Ga-RM2 PET–MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial-Reference-Cited by-同舟云学术

68Ga-RM2 PET–MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial

Published:2024-04 Issue:4 Volume:25 Page:501-508
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Duan Heying^ORCID,Moradi Farshad,Davidzon Guido A,Liang Tie,Song Hong,Loening Andreas M,Vasanawala Shreyas,Srinivas Sandy,Brooks James D,Hancock Steven,Iagaru Andrei^ORCID

Funder

U.S. Department of Defense

Publisher

Elsevier BV

Reference29 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer;Cornford;Eur Urol,2021

3. Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

4. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference;Roach;Int J Radiat Oncol Biol Phys,2006

5. Application of next-generation imaging in biochemically recurrent prostate cancer;Moul;Prostate Cancer Prostatic Dis,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Beyond the AJR: PET/MRI Using ⁶⁸Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer Treatment;American Journal of Roentgenology;2024-05-15